Laborie Medical Technologies
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Laborie Medical Technologies sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Laborie Medical Technologies: 5 sponsored US clinical trials, 2 recruiting.
Laborie Medical Technologies sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Urinary Incontinence, Urge, with 1 trials.
Upper-quartile sponsor footprint
Laborie Medical Technologies sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
EvaluatIng Normal Values for traditionaL anorectaL fUnction paraMeters With aIr Charged aNd Solid State HRAM catheTErs ("ILLUMINATE" Study)
NCT06805240
NXT Post-Market Clinical Follow-up
NCT06336304
T-DOC® NXT Clinical Investigation
NCT03615001
T-DOC® 5 Fr Pediatric Clinical Investigation
NCT03429270
Tetra-NIRS Clinical Study
NCT00871975
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
Where Laborie Medical Technologies enrollment is open (later-stage tilt)
2 recruiting of 5 indexed (40% open); 2 completed (40%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Urinary Incontinence, Urge (1 trial), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Laborie Medical Technologies: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
Laborie Medical Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this Laborie Medical Technologies page
5 registered trials is a research-attention snapshot, not an endorsement of Laborie Medical Technologies or any single study.
- 2 of Laborie Medical Technologies's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Urinary Incontinence, Urge is the condition Laborie Medical Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Urinary Incontinence, Urge trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Laborie Medical Technologies pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.